TfR-T12 short peptide and pH sensitive cell transmembrane peptide modified nano-composite micelles for glioma treatment via remodeling tumor microenvironment

Nanomedicine. 2022 Apr:41:102516. doi: 10.1016/j.nano.2022.102516. Epub 2022 Feb 5.

Abstract

Two kinds of amphiphilic block copolymers of TfR-T12-PEG-PLGA and TATH7-PEG-PLGA were synthesized to self-assembly nano-composite micelles for encapsulating paclitaxel and imiquimod synchronously. TfR-T12 peptide modified nano-composite micelles can pass through BBB in a TfR-mediated way to achieve targeted delivery of chemotherapeutic drugs, and pH sensitive TATH7 peptide modified nano-composite micelles enhanced uptake efficiency more significantly under pH 5.5 medium than pH 7.4 medium. The results of pharmacodynamic evaluation in vivo showed that the nano-composite micelles had achieved good anti-tumor effect in subcutaneous and normotopia glioma models, and effectively prolonged the life cycle of tumor-bearing mice. The nano-composite micelles regulated the immunosuppression phenomenon of tumor microenvironment significantly, and promoted the M1 polarization of TAMs, then enhanced the proliferation and activation of CD8+ T cells in tumor microenvironment. It comes to conclusion that the nano-composite micelle achieves the purpose of effective treatment of glioma by chemotherapy combined with immunotherapy.

Keywords: Blood–brain barrier; Chemo-immunotherapy; Glioma therapy; Tumor-associated macrophage; pH sensitive micelles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes / pathology
  • Cell Line, Tumor
  • Glioma* / pathology
  • Hydrogen-Ion Concentration
  • Mice
  • Micelles*
  • Paclitaxel / pharmacology
  • Paclitaxel / therapeutic use
  • Peptides / therapeutic use
  • Polyethylene Glycols / therapeutic use
  • Tumor Microenvironment

Substances

  • Micelles
  • Peptides
  • Polyethylene Glycols
  • Paclitaxel